IDH2 and ganglioglioma: Mutations in KRAS were revealed in three tumours: an anaplastic astrocytoma, IDH-wildtype; an anaplastic oligodendroglioma, IDH-mutant with a 1p/19q codeletion; and a ganglioglioma.